哥伦比亚波哥大一家转诊中心2019年对B族链球菌定植孕妇预防早发型新生儿脓毒症推荐意见的依从性
该回顾性队列纳入2019年7月1日至12月31日波哥大一家私立高级别诊所的足月孕妇及其新生儿共1928例,评估B族链球菌筛查与产时抗生素预防的依从性、定植率及早期不良围产结局。筛查依从性68.0%(95%CI 66-70.1),产时抗生素给药依从性87.9%(95%CI 87.8-88),非指征抗生素使用占14.7%,最终抗生素预防依从性86.3%。B族链球菌定植率12.5%(95%CI 10.7-14.3),新生儿住院发生率27.5%(95%CI 16.3-33.7)。未见可归因于筛查状态、定植或B族链球菌抗生素预防的死亡或早发型新生儿脓毒症病例。
要点
- 足月孕妇B族链球菌定植率为12.5%(95%CI 10.7-14.3),新生儿住院发生率为27.5%(95%CI 16.3-33.7)。
- 筛查依从性为68.0%(95%CI 66-70.1),产时抗生素给药依从性为87.9%(95%CI 87.8-88)。
- 非指征抗生素使用占14.7%,使最终抗生素预防依从性降至86.3%。
- 未见可归因于筛查状态、定植或B族链球菌抗生素预防的死亡或早发型新生儿脓毒症病例。
适用人群与场景
- 2019年7月1日至12月31日在波哥大一家私立高级别诊所就诊的足月孕妇及其新生儿,共1928例。
研究设计与关键结果
- 回顾性队列研究,纳入1928例足月孕妇及其新生儿;筛查依从性68.0%(95%CI 66-70.1),产时抗生素给药依从性87.9%(95%CI 87.8-88)。
- 非指征抗生素使用占14.7%,最终抗生素预防依从性86.3%;B族链球菌定植率12.5%(95%CI 10.7-14.3)。
- 新生儿住院发生率27.5%(95%CI 16.3-33.7);未见可归因于筛查状态、定植或B族链球菌抗生素预防的死亡或早发型新生儿脓毒症病例。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,需在其他机构开展进一步研究以确定对该指南的依从性,尤其是收治补贴制度参保用户、覆盖最脆弱人群的机构。
- 作者认为,需开展新的B族链球菌定植率人群研究以及比较普遍筛查与基于危险因素的抗生素预防的成本效果研究。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To assess adherence to screening recommendations for the prevention of neonatal sepsis, and describe the prevalence of colonization by Group B streptococcus (GBS) as well as the perinatal outcomes associated with colonization by this bacterium.
MATERIAL AND METHODS: Retrospective cohort study that included pregnant women at term and their newborns, seen at a private high-complexity clinic in Bogota, between July 1 and December 31, 2019. Adherence to screening and intrapartum antibiotic prophylaxis in pregnant women colonized with group B streptococcus, as well as the prevalence of colonization and early adverse perinatal outcomes were assessed.
RESULTS: Overall, 1928 women were included. Adherence to screening was 68.0 % (95 % CI: 66-70.1) and 87.9 % to intrapartum antibiotic administration (95 % CI: 87.8-88); non-indicated use of antibiotics occurred in 14.7 % of the women, for 86.3 % final adherence to antibiotic prophylaxis. The prevalence of GBS colonization was 12.5 % (95 % CI: 10.7-14.3); the incidence of neonatal hospitalization was 27.5 % (95 % CI: 16.3-33.7). There were no cases of mortality or early neonatal sepsis attributable to screening status, colonization or prophylactic antibiotics for GBS.
CONCLUSIONS: Additional studies in other centers are required in order to determine adherence to this guideline, particularly in those that receive users affiliated to the subsidized regime which covers the most vulnerable population. Also, new population studies of GBS prevalence and cost-effectiveness of universal screening compared to risk factor-based antibiotic prophylaxis are needed.
OBJETIVOS: evaluar la adherencia a las recomendaciones de tamización para la prevención de la sepsis neonatal, describir la prevalencia de colonización por estreptococo del grupo B y los desenlaces perinatales asociados a la colonización por esta bacteria.
MATERIALES Y MÉTODOS: estudio de cohorte retrospectiva que incluyó gestantes a término y sus recién nacidos, en una clínica universitaria privada de alta complejidad en Bogotá, entre el 1 de julio y el 31 de diciembre de 2019. Se evaluó la adherencia a la tamización y a la profilaxis antibiótica intraparto para las gestantes colonizadas con EGB, la prevalencia de colonización y los desenlaces perinatales adversos tempranos.
RESULTADOS: se incluyeron 1.928 mujeres. La adherencia a la tamización fue de 68,0 % (IC 95%: 66-70,1), a la administración de antibióticos intraparto de 87,9 % (IC 95 %: 87,8 -88), pero hubo uso no indicado de antibióticos en 14,7 % de mujeres para una adherencia final a profilaxis antibiótica de 86,3 %. La prevalencia de colonización por EGB fue 12,5 % (IC 95 %: 10,7-14,3), la incidencia de hospitalización neonatal fue de 27,5 % (IC 95 %: 16,3-33,7); no hubo casos de mortalidad ni sepsis neonatal temprana atribuibles al estado de tamización, colonización o profilaxis antibiótica para EGB.
CONCLUSIONES: se requieren nuevos estudios en otras instituciones para determinar la adherencia a esta guía, en especial en aquellas regiones que atienden usuarias adscritas al régimen subsidiado, con cobertura a la población más vulnerable, así como nuevos estudios poblacionales de prevalencia de EGB y costo-efectividad de la estrategia de tamización universal en comparación con la profilaxis antibiótica basada en factores de riesgo.
OBJECTIVES:: To assess adherence to screening recommendations for the prevention of neonatal sepsis, and describe the prevalence of colonization by Group B streptococcus (GBS) as well as the perinatal outcomes associated with colonization by this bacterium.
MATERIAL AND METHODS:: Retrospective cohort study that included pregnant women at term and their newborns, seen at a private high-complexity clinic in Bogota, between July 1 and December 31, 2019. Adherence to screening and intrapartum antibiotic prophylaxis in pregnant women colonized with group B streptococcus, as well as the prevalence of colonization and early adverse perinatal outcomes were assessed.
RESULTS:: Overall, 1928 women were included. Adherence to screening was 68.0 % (95 % CI: 66-70.1) and 87.9 % to intrapartum antibiotic administration (95 % CI: 87.8-88); non-indicated use of antibiotics occurred in 14.7 % of the women, for 86.3 % final adherence to antibiotic prophylaxis. The prevalence of GBS colonization was 12.5 % (95 % CI: 10.7-14.3); the incidence of neonatal hospitalization was 27.5 % (95 % CI: 16.3-33.7). There were no cases of mortality or early neonatal sepsis attributable to screening status, colonization or prophylactic antibiotics for GBS.
CONCLUSIONS:: Additional studies in other centers are required in order to determine adherence to this guideline, particularly in those that receive users affiliated to the subsidized regime which covers the most vulnerable population. Also, new population studies of GBS prevalence and cost-effectiveness of universal screening compared to risk factor-based antibiotic prophylaxis are needed.
参考来源
- Ospino-Muñoz AM, Bonza-González EA, Arévalo-Mojica CD, et al. Adherence to recommendations for preventing early neonatal sepsis associated with Streptococcus agalactiae colonization in a referral center in Bogotá, Colombia, 2019. Rev Colomb Obstet Ginecol. 2022. PMID: 36331302. doi:10.18597/rcog.3917
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。